ArticleWorld journal of urology2016

Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.

Elisabeth E Fransen van de Putte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.